Clinical Decision Support Systems Market Size to Reach USD 2,634.78 Million in 2028 | Industry Trend – Rise in Geriatric Population and Increasing Patient Pool

Rising prevalence of chronic and acute diseases worldwide and rapid adoption of clinical decision support systems in healthcare settings are among the key factors driving market revenue growth

Emergen Research has published its latest report titled “Clinical Decision Support Systems (CDSS) Market, By Component (Services, Hardware, Software), By Product (Integrated CDSS, Standalone CDSS), By Type (Therapeutic CDSS, Diagnostic CDSS), By Mode of Delivery (On-premise CDSS, Web-based CDSS, Cloud-based CDSS), By Level of Interactivity (Active CDSS, Passive CDSS), By Setting (Inpatient, Ambulatory Care), By Usage (Knowledge-based, Expert Laboratory Information System, Machine Learning Systems), By Application (Drug Databases, Care Plans, Diagnostic Decision Support, Disease Reference, Others), By End-use (Hospitals & Clinics, Diagnostic Centers, Retail Pharmacies, Others), and By Region Forecast to 2028”

According to Emergen Research, the global clinical decision support systems (CDSS) market size was USD 1,240.30 million in 2020 and is expected to reach USD 2,634.78 million in 2028 and register a revenue CAGR of 9.5% during the forecast period, 2021-2028.

Market Dynamics:

Major factors contributing to the global clinical decision support systems (CDSS) market revenue growth include rapid adoption of cloud computing solutions in the healthcare sector, growing trends of telehealth and telemedicine, evolution of various eHealth platforms, and growing rate of hospitalizations and increased need for better patient data management, especially during the ongoing COVID-19 pandemic. Clinical decision support systems enable healthcare providers to analyze large volumes of medical data, make more informed healthcare decisions, and improve patient outcomes. Multiple benefits offered by these systems are improved patient safety, fewer medication errors, reliable and consistent information, and lesser chances of misdiagnosis.

Click Here to Access Free sample PDF Copy of the Report@ https://www.emergenresearch.com/request-sample/64

CDSS also helps increase patient-caregiver coordination through better-quality video calls and chats, and allows immediate patient access to critical health-related information. Integration of artificial intelligence, machine learning, big data analytics, and other emerging technologies in healthcare, rising prevalence of chronic and lifestyle-induced diseases, growing patient pool, and increasing adoption of advanced clinical decision support systems for enhanced diagnosis, monitoring, and management of diseases are among the other factors expected to boost market revenue growth.

COVID-19 Impact Analysis:

  • Social distancing and restrictions severely disrupted businesses and operations
  • Lockdowns caused disruptions in transportation and logistics
  • Impacted manufacturing activities and mining operations globally
  • Took a toll on economy of various countries
  • Caused sudden and drastic downturn in economic activity
  • Disrupted agriculture, fisheries, dairy, and other sectors
  • Caused loss of employment and financial crisis
  • Supply impacts were further compounded owing to reduced disposable income
  • Emergence of variants  continue to cause concerns and impact normal routines

Cloud-based CDSS Segment Accounted for Largest Revenue Share in 2020:

Based on mode of delivery, the global clinical decision support systems (CDSS) market is segmented into on-premise CDSS, web-based CDSS, and cloud-based CDSS. The cloud-based CDSS segment dominated other segments in terms of revenue share in the global market in 2020. Rapid adoption of state-of-the-art technologies such as AI, big data, and Internet of Things (IoT) in the healthcare sector, growing demand for electronic health records (EHRs) and electronic medical records (EMRs), and increasing deployment of cloud-based CDSS due to benefits such as easy management of data, enhanced data security, and reduced time and efforts are key factors driving revenue growth of this segment.

Looking for Discount [Click on the link] @ https://www.emergenresearch.com/request-discount/64

Hospitals & Clinics Segment to Account for Fastest Revenue CAGR:

Based on end-use, the hospitals & clinics segment is expected to register the fastest revenue growth rate in the global clinical decision support systems (CDSS) market over the forecast period. Growing geriatric population, rising prevalence of chronic and infectious diseases, increasing patient pool, and rising availability of well-resourced diagnostic and operating rooms are among the major factors boosting revenue growth this segment.

North America Accounted for Largest Revenue Share in 2020:

Among regional markets, the North America clinical decision support systems (CDSS) market accounted for the largest revenue share in the global market in 2020. Rise in geriatric population, growing awareness of regular health checkups, rising focus of healthcare providers on improving the quality of patient care, rapid adoption of advanced healthcare IT solutions, and growing availability of highly advanced medical diagnostic facilities in the region are major factors supporting the regional market revenue growth.

Major Companies in the Global Clinical Decision Support Systems (CDSS) Market Include:

  • Cerner Corporation
  • Epic Systems Corporation
  • Zynx Health
  • Allscripts Healthcare Solutions Inc.
  • IBM Corporation
  • McKesson Corporation
  • Siemens Healthineers
  • Meditech
  • Philips Healthcare
  • Wolters Kluwer Health

Have a look at Report Description and Table of Contents of Market Report@ https://www.emergenresearch.com/industry-report/clinical-decision-support-systems-cdss-market

For the purpose of this report, Emergen Research has segmented the global clinical decision support systems (CDSS) market on the basis of component, product, type, mode of delivery, level of interactivity, setting outlook, usage, application, end-use, and region:

Component Outlook (Revenue, USD Million; 2018-2028)

  • Services
  • Hardware
  • Software

Product Outlook (Revenue, USD Million; 2018-2028)

  • Integrated CDSS
  • Standalone CDSS

Type Outlook (Revenue, USD Million; 2018-2028)

  • Therapeutic CDSS
  • Diagnostic CDSS

Mode of Delivery Outlook (Revenue, USD Million; 2018-2028)

  • On-premise CDSS
  • Web-based CDSS
  • Cloud-based CDSS

Level of Interactivity Outlook (Revenue, USD Million; 2018-2028)

  • Active CDSS
  • Passive CDSS

Setting Outlook (Revenue, USD Million; 2018-2028)

  • Inpatient
  • Ambulatory Care

Usage Outlook (Revenue, USD Million; 2018-2028)

  • Knowledge-based
  • Expert Laboratory Information System
  • Machine Learning Systems

Application Outlook (Revenue, USD Million; 2018-2028)

  • Drug Databases
  • Care Plans
  • Diagnostic Decision Support
  • Disease Reference
  • Others

End-use Outlook (Revenue, USD Million; 2018-2028)

  • Hospitals & Clinics
  • Diagnostic Centers
  • Retail Pharmacies
  • Others

Region Outlook (Revenue, USD Million; 2018-2028)

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • BENELUX
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Saudi Arabia
    • U.A.E.
    • South Africa
    • Turkey
    • Rest of Middle East & Africa

Explore Similar Reports offered by Emergen Research:

The global nutrigenomics market size reached USD 389.4 Million in 2020 and is expected to register a CAGR of 16.2% during the forecast period.

The global Sanger sequencing services market size was significantly robust in 2020 and is expected to register steady revenue CAGR over the forecast period. Increasing advancements in sequencing techniques, benefits of Sanger sequencing, and rising investments to accelerate R&D activities in genomics are key factors expected to drive market revenue growth over the forecast period.

The global whole exome sequencing (WES) market size was significantly robust in 2020 and is expected to register a steady revenue CAGR during the forecast period.

The global health data archiving market size is expected to reach USD 9.28 Billion in 2028 and register a revenue CAGR of 14.1% during the forecast period.

The global gel documentation system market size reached USD 291.5 Million in 2020 and is expected to register a revenue CAGR of 3.6% during the forecast period.

About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Visit for More Insights: https://www.emergenresearch.com/insights

Explore Our Custom Intelligence services | Growth Consulting Services

Read Our Press release@ https://www.emergenresearch.com/press-release/global-clinical-decision-support-systems-cdss-market

Back to news